2025 · 3rd Quarter (July 1 - Sep 30)

HIMS & HERS HEALTH, INC.

Filed by HIMS & HERS HEALTH, INC..

Open official filing

Source-reported fields

Filing overview

Type: 3rd Quarter - Amendment
Posted: Oct 20, 2025
Income: Not reported
Expenses: $320,000.00
Registrant: HIMS & HERS HEALTH, INC.
Client: HIMS & HERS HEALTH, INC.
Filing UUID: 322cc3ce-4819-4ff5-b308-3d67ba65a6c3
Termination date: Not reported

Expense method: A

Literal source text

Lobbying issues and bill citations

HCR · Health Issues

Drug Enforcement Administration Rule (DEA407) concerning Telemedicine Prescribing of Controlled Substances Discussions concerning proposed legislation related to access to compounded drugs and drug shortages H.R.5316 - Drug Shortage Compounding Patient Access Act of 2025 H.R.4605 - End Prescription Drug Ads Now Act H.R.238 - Healthy Technology Act of 2025 S.5040 - Protecting Patients from Deceptive Drug Ads Online Act S.2068 - End Prescription Drug Ads Now Act

Literal federal measure citations: H.R.5316, H.R.4605, H.R.238, S.5040, S.2068

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.